<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.6.0 for Hugo" />
  

  
  












  
  










  







  
  

  
  
  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." />

  
  <link rel="alternate" hreflang="en-us" href="https://example.com/tag/cancers/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  
    
    <script src="/js/mathjax-config.js"></script>
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    

    
    
    
    
      
      
    
    
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.7579f2ea081d74b9cb40a7d984071feb.css" />

  
  
  
  
  
  
  
    
    
    <link rel="stylesheet" href="/css/libs/chroma/github-light.min.css" title="hl-light" media="print" onload="this.media='all'" >
    <link rel="stylesheet" href="/css/libs/chroma/dracula.min.css" title="hl-dark" media="print" onload="this.media='all'" disabled>
  

  
  



  


  


  




  
  
  

  
  
    <link rel="alternate" href="/tag/cancers/index.xml" type="application/rss+xml" title="BM Sci-Tech Memento" />
  

  
  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  
  <link rel="icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://example.com/tag/cancers/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@wowchemy" />
    <meta property="twitter:creator" content="@wowchemy" />
  
  <meta property="og:site_name" content="BM Sci-Tech Memento" />
  <meta property="og:url" content="https://example.com/tag/cancers/" />
  <meta property="og:title" content="Cancers | BM Sci-Tech Memento" />
  <meta property="og:description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." /><meta property="og:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta property="og:updated_time" content="2023-02-01T00:00:00&#43;00:00" />
    
  

  



  


  <title>Cancers | BM Sci-Tech Memento</title>

  
  
  
  











</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   "  >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.613040fe4f2c0f007b4dcb64404201cb.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          

          

          
          
          
          

          
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/tool/"><span>Tools</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/docs/"><span>Notes</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener"><span>PubMed</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://licore.netlify.app/" target="_blank" rel="noopener"><span>MII</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        

        
        
        <li class="nav-item">
          <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        
        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    
    
    

    












  

  
  
  
    
  
<div class="universal-wrapper pt-3">
  <h1>Cancers</h1>

  

  
</div>



<div class="universal-wrapper">
  

  
  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/review/35966580/" >Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke</a>
    </div>

    
    <a href="/review/35966580/"  class="summary-link">
      <div class="article-style">
        Abstract
Hypoxia is a central pathophysiological component in cancer, myocardial infarction and ischemic stroke, which represent the most common medical conditions resulting in long-term disability and death. Recent evidence suggests common signaling pathways in these diverse settings mediated by non-coding RNAs (ncRNAs), which are packaged in extracellular vesicles (EVs) protecting ncRNAs from degradation.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 18 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.thno.org/v12p5776.htm" target="_blank" rel="noopener">
    Theranostics</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35966580/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373807/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/review/35966580/" >
      <img src="/review/35966580/featured_hu8847de4b1032994b7e1ff424f46f1bdb_110677_150x0_resize_q75_h2_lanczos.webp" height="100" width="150"
           alt="Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35843865/" >SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization</a>
    </div>

    
    <a href="/article/35843865/"  class="summary-link">
      <div class="article-style">
        Abstract
Sustained activation of signal transducer and activator of transcription 3 (STAT3) is a critical contributor in tumorigenesis and chemoresistance, thus making it an attractive cancer therapeutic target. Here, SH2 domain-containing adapter protein F (SHF) is identified as a tumor suppressor in glioblastoma Multiforme (GBM) and its negative regulation of STAT3 activity is characterized.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Sunday, 17 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://onlinelibrary.wiley.com/doi/10.1002/advs.202200169" target="_blank" rel="noopener">
    Advanced Science</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35843865/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475553/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35843865/" >
      <img src="/article/35843865/featured_hua8f0250f537d9b3456bc017ffc5887e7_288758_150x0_resize_q75_h2_lanczos.webp" height="144" width="150"
           alt="SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35579947/" >KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer</a>
    </div>

    
    <a href="/article/35579947/"  class="summary-link">
      <div class="article-style">
        Abstract
Lymph node (LN) metastasis occurs frequently in pancreatic ductal adenocarcinoma (PDAC) and predicts poor prognosis for patients. The KRASG12D mutation confers an aggressive PDAC phenotype that is susceptible to lymphatic dissemination.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Friday, 15 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.jci.org/articles/view/157644" target="_blank" rel="noopener">
    Journal of Clinical Investigation</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35579947/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282935/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35579947/" >
      <img src="/article/35579947/featured_hu3b7bdc4d47e26446e3d0ba8d60741e15_120296_150x0_resize_q75_h2_lanczos.webp" height="144" width="150"
           alt="KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35849876/" >Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract</a>
    </div>

    
    <a href="/article/35849876/"  class="summary-link">
      <div class="article-style">
        Abstract
Background: Tankyrase inhibition stabilises AXINs and antagonises the Wnt/β-catenin pathway in adenomatous polyposis coli (APC)-mutated colorectal cancer (CRC), suggesting that tankyrase is a potential therapeutic target for APC-mutated CRC. However, clinical trials on reported tankyrase inhibitors have been severely limited by on-target toxicity in the gastrointestinal (GI) tract.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Friday, 15 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ejcancer.com/article/S0959-8049%2822%2900382-3/fulltext" target="_blank" rel="noopener">
    European Journal of Cancer</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35849876/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/review/35839443/" >Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices</a>
    </div>

    
    <a href="/review/35839443/"  class="summary-link">
      <div class="article-style">
        Abstract
There exists a tremendous opportunity in identifying and determining the appropriate predictive and prognostic biomarker(s) for risk stratification of patients with colorectal cancers (CRCs). Circulating tumor DNA (ctDNA) has emerged as a promising prognostic and possibly predictive biomarker in the personalized management of patients with CRCs.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Friday, 15 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://ascopubs.org/doi/10.1200/JCO.21.02615" target="_blank" rel="noopener">
    Journal of Clinical Oncology</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35839443/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390824/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/review/35839443/" >
      <img src="/review/35839443/featured_hua580d06da574a3504a4c118e7f3b7d2d_338574_150x0_resize_q75_h2_lanczos.webp" height="130" width="150"
           alt="Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35857588/" >TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets</a>
    </div>

    
    <a href="/article/35857588/"  class="summary-link">
      <div class="article-style">
        Abstract
γδ T cells represent a substantial fraction of intestinal lymphocytes at homeostasis, but they also constitute a major lymphocyte population infiltrating colorectal cancers (CRCs); however, their temporal contribution to CRC development or progression remains unclear.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Thursday, 14 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.science.org/doi/10.1126/science.abj8695" target="_blank" rel="noopener">
    Science</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35857588/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326786/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35857588/" >
      <img src="/article/35857588/featured_hu02a48b9914fa8538cc8286159f40761f_6146_150x0_resize_q75_h2_lanczos.webp" height="162" width="150"
           alt="TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35831279/" >Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth</a>
    </div>

    
    <a href="/article/35831279/"  class="summary-link">
      <div class="article-style">
        Abstract
Sphingosine kinase 1 (SphK1) and sphingosine kinase (SphK2) are both important therapeutic targets of non-small cell lung cancer (NSCLC). SKI-349 is a novel, highly efficient and small molecular SphK1/2 dual inhibitor.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Tuesday, 12 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41419-022-05049-4" target="_blank" rel="noopener">
    Cell Death & Disease</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35831279/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279331/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35831279/" >
      <img src="/article/35831279/featured_hu2e57d5c63a5e857f6f6b849a1107f423_476916_150x0_resize_q75_h2_lanczos.webp" height="166" width="150"
           alt="Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35818076/" >LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway</a>
    </div>

    
    <a href="/article/35818076/"  class="summary-link">
      <div class="article-style">
        Abstract
Background: Prostate cancer (PCa) is one of the most common malignant tumors in the male urinary system. In recent years, the morbidity and mortality of PCa have been increasing due to the limited effects of existing treatment strategies.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Sunday, 10 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://cancerci.biomedcentral.com/articles/10.1186/s12935-022-02637-4" target="_blank" rel="noopener">
    Cancer Cell International</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35818076/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275192/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35818076/" >
      <img src="/article/35818076/featured_hu83185406d2e9e90d25bc549334d4b66a_33064_150x0_resize_q75_h2_lanczos.webp" height="113" width="150"
           alt="LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35802647/" >Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8&#43; T Cells and Antitumor Immunity</a>
    </div>

    
    <a href="/article/35802647/"  class="summary-link">
      <div class="article-style">
        Abstract
Tissue-resident memory CD8+ T (TRM) cells have been associated with robust protective antitumor immune responses and improved prognosis of patients with cancer. Therefore, therapeutic strategies that modulate either the production or activity of TRM cells could be effective for treating cancer.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Saturday, 09 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://aacrjournals.org/cancerres/article-abstract/82/17/3130/708283/Dopamine-Signaling-Promotes-Tissue-Resident-Memory" target="_blank" rel="noopener">
    Cancer Research</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35802647/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35810190/" >Multi-modal molecular programs regulate melanoma cell state</a>
    </div>

    
    <a href="/article/35810190/"  class="summary-link">
      <div class="article-style">
        Abstract
Melanoma cells display distinct intrinsic phenotypic states. Here, we seek to characterize the molecular regulation of these states using multi-omic analyses of whole exome, transcriptome, microRNA, long non-coding RNA and DNA methylation data together with reverse-phase protein array data on a panel of 68 highly annotated early passage melanoma cell lines.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Saturday, 09 July 2022 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41467-022-31510-1" target="_blank" rel="noopener">
    Nature Communications</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35810190/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271073/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35810190/" >
      <img src="/article/35810190/featured_huc1c0765d925e7d9aae9f05adc45f4eb5_702168_150x0_resize_q75_h2_lanczos.webp" height="187" width="150"
           alt="Multi-modal molecular programs regulate melanoma cell state" loading="lazy">
    </a>
    
  </div>
</div>

  

  
<nav class="mt-1">
  <ul class="pagination justify-content-center">
    
    <li class="page-item"><a class="page-link" href="/tag/cancers/page/18/">&laquo;</a></li>
    
    
    <li class="page-item"><a class="page-link" href="/tag/cancers/page/20/">&raquo;</a></li>
    
  </ul>
</nav>


</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  












  

  

  

  
  






  
  <p class="powered-by copyright-license-text">
    Copyright © 2023 | Biomedist | All rights reserved.
  </p>
  




  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  


<script src="/js/vendor-bundle.min.d26509351aa0ff874abbee824e982e9b.js"></script>




  

  
  

  













  
  <script id="search-hit-fuse-template" type="text/x-template">
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script>
  
    <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
  












  
  
  
  
  
  
  







<script id="page-data" type="application/json">{"use_headroom":true}</script>



  <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>








  
  


<script src="/en/js/wowchemy.min.54dd6e4d8f2e4b1d098381b57f18dd83.js"></script>























</body>
</html>
